Net Cash Provided by (Used in) Operating Activities of Nascent Biotech Inc. from 31 Mar 2014 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Nascent Biotech Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Mar 2014 to 30 Jun 2024.
  • Nascent Biotech Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 30 Jun 2024 was $324,729, a 100% decline year-over-year.
  • Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $1,186,066, a 34% increase from 2022.
  • Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $1,787,228, a 532% decline from 2021.
  • Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $413,479.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Nascent Biotech Inc. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $324,729 -$162,023 -100% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2025 Q1
Q2 2023 $162,706 +$181,133 +53% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2025 Q1
Q2 2022 $343,839 -$831,744 -170% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2024 Q1
Q2 2021 $487,905 +$540,691 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2023 Q1
Q2 2020 $52,786 +$74,379 +58% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2022 Q1
Q2 2019 $127,165 +$53,724 +30% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2021 Q1
Q2 2018 $180,889 +$27,913 +13% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q1
Q2 2017 $208,802 +$299,326 +59% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018 2019 Q1
Q2 2016 $508,128 -$7,683 -1.5% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2018 Q1
Q2 2015 $500,445 -$313,457 -168% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2017 Q1
Q2 2014 $186,988 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015 2016 Q1

Nascent Biotech Inc. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,186,066 +$601,162 +34% 01 Apr 2023 31 Mar 2024 10-K 01 Jul 2024 2024 FY
2022 $1,787,228 -$2,200,707 -532% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024 2024 FY
2021 $413,479 +$1,400,262 01 Apr 2021 31 Mar 2022 10-K/A 03 Jul 2023 2023 FY
2020 $986,783 -$432,458 -78% 01 Apr 2020 31 Mar 2021 10-K 15 Jun 2022 2022 FY
2019 $554,325 +$157,483 +22% 01 Apr 2019 31 Mar 2020 10-K 08 Jul 2021 2021 FY
2018 $711,808 +$512,573 +42% 01 Apr 2018 31 Mar 2019 10-K 22 Jun 2020 2020 FY
2017 $1,224,381 -$455,537 -59% 01 Apr 2017 31 Mar 2018 10-K 12 Jul 2019 2019 FY
2016 $768,844 -$598,423 -351% 01 Apr 2016 31 Mar 2017 10-K 29 Jun 2018 2018 FY
2015 $170,421 +$302,876 +64% 01 Apr 2015 31 Mar 2016 10-K 29 Jun 2017 2017 FY
2014 $473,297 -$343,768 -265% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016 2016 FY
2013 $129,529 01 Apr 2013 31 Mar 2014 10-K 02 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.